Ilkka O. Koskivuo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ilkka O. Koskivuo has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Emma K. Rousi
Department of Plastic and General Surgery, Turku University Hospital and University of Turku
2 shared publications - Susanna Juteau
Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
2 shared publications - Veli-Matti Kähäri
Department of Dermatology, University of Turku and Turku University Hospital, Turku, Finland.
2 shared publications - Akira Takeda
University of Turku
1 shared publication - Anni Kauko
Department of Internal Medicine, University of Turku and Turku University Hospital, Finland (M.V., L.-F.Y., A.K., T.N.).
1 shared publication - Diana Lehotina
MediCity Research Laboratory, University of Turku, Turku, Finland
1 shared publication
Latest Publications
- Open Access
- 28 February 2026
- Published by SAGE Publications in Scandinavian Journal of Surgery
- Vol. 115 (2) , 211-217
Breast MRI in ductal carcinoma in situ (DCIS) of the breast in clinical practice
Background and Aims: Ductal carcinoma in situ (DCIS) is a non-invasive form of breast cancer with increasing incidence in recent decades. Early detection and accurate staging of DCIS are crucial for determining the appropriate treatment approach, with breast-conserving surgery (BCS) being the standard when feasible. The role of preoperative magnetic resonance imaging (MRI) in DCIS remains controversial, particularly in relation to its potential to identify incidental findings that may influence surgical decisions. This study aims to evaluate the clinical value of preoperative MRI in patients with pure DCIS, focusing on its impact on surgical management and the potential influence of incidental findings on mastectomy rates. Material and Methods: A retrospective review of 91 patients with pure DCIS who underwent preoperative MRI between 2014 and 2019 at Tampere University Hospital, Finland. Patients were divided into two groups: “No incidental MRI findings” and “Incidental MRI findings” with the latter leading to further imaging and biopsies. Surgical approaches and the time delay between diagnosis and surgery were compared. Tumor sizes estimated by MRI, mammography, ultrasound, and histopathology were assessed for correlation. Results: Incidental MRI findings were identified in 22% of patients, with a higher mastectomy rate in “Incidental MRI findings” (65.0%) group compared to the “No incidental MRI findings” (41%) group. Despite the higher mastectomy rate in the “Incidental MRI findings” group, most incidental findings were benign. The evaluated mean tumor size was largest on MRI (48 mm) compared to mammography (32 mm) and ultrasound (27 mm). MRI was found to overestimate tumor size, unlike mammography and ultrasound. No significant difference in the delay between MRI and surgery was observed between the two groups. Conclusions: In DCIS, incidental findings on MRI were associated with higher mastectomy rate, but overtreatment or unnecessary mastectomies were not detected. MRI may assist surgical decision-making in patients with pure DCIS.
- 28 February 2026
- Published by SAGE Publications in Scandinavian Journal of Surgery
- Vol. 115 (2) , 211-217
Open AccessBreast MRI in ductal carcinoma in situ (DCIS) of the breast in clinical practice
Background and Aims: Ductal carcinoma in situ (DCIS) is a non-invasive form of breast cancer with increasing incidence in recent decades. Early detection and accurate staging of DCIS are crucial for determining the appropriate treatment approach, with breast-conserving surgery (BCS) being the standard when feasible. The role of preoperative magnetic resonance imaging (MRI) in DCIS remains controversial, particularly in relation to its potential to identify incidental findings that may influence surgical decisions. This study aims to evaluate the clinical value of preoperative MRI in patients with pure DCIS, focusing on its impact on surgical management and the potential influence of incidental findings on mastectomy rates. Material and Methods: A retrospective review of 91 patients with pure DCIS who underwent preoperative MRI between 2014 and 2019 at Tampere University Hospital, Finland. Patients were divided into two groups: “No incidental MRI findings” and “Incidental MRI findings” with the latter leading to further imaging and biopsies. Surgical approaches and the time delay between diagnosis and surgery were compared. Tumor sizes estimated by MRI, mammography, ultrasound, and histopathology were assessed for correlation. Results: Incidental MRI findings were identified in 22% of patients, with a higher mastectomy rate in “Incidental MRI findings” (65.0%) group compared to the “No incidental MRI findings” (41%) group. Despite the higher mastectomy rate in the “Incidental MRI findings” group, most incidental findings were benign. The evaluated mean tumor size was largest on MRI (48 mm) compared to mammography (32 mm) and ultrasound (27 mm). MRI was found to overestimate tumor size, unlike mammography and ultrasound. No significant difference in the delay between MRI and surgery was observed between the two groups. Conclusions: In DCIS, incidental findings on MRI were associated with higher mastectomy rate, but overtreatment or unnecessary mastectomies were not detected. MRI may assist surgical decision-making in patients with pure DCIS.
- Open Access
Breast Cancer Remodels Lymphatics in Sentinel Lymph Nodes
Cancer metastasis to sentinel lymph nodes (LNs) is often the first marker of potential disease progression. Although it is recognized that tumor-induced lymphangiogenesis facilitates metastasis into LNs in murine models, tumor-induced alterations in human lymphatic vessels remain obscure. We used single-cell RNA sequencing to profile lymphatic endothelial cell (LEC) subsets in paired metastatic and non-metastatic LNs obtained from patients with treatment-naïve breast cancer. Tumor metastasis decreases immunoregulatory LEC subsets, such as PD-L1 + subcapsular sinus LECs, while inducing an increase in capillary-like CD200 + HEY1 + LECs. Matrix Gla protein (MGP) was the most upregulated gene in metastatic LN LECs, and its expression on LECs was TGF-β and VEGF dependent. Upregulated MGP promotes cancer cell adhesion to LN lymphatics. Thus, breast cancer cell metastasis to LNs remodels LEC subsets in human LNs and escalates MGP expression, potentially facilitating cancer cell dissemination through the lymphatic system.
Open AccessBreast Cancer Remodels Lymphatics in Sentinel Lymph Nodes
Cancer metastasis to sentinel lymph nodes (LNs) is often the first marker of potential disease progression. Although it is recognized that tumor-induced lymphangiogenesis facilitates metastasis into LNs in murine models, tumor-induced alterations in human lymphatic vessels remain obscure. We used single-cell RNA sequencing to profile lymphatic endothelial cell (LEC) subsets in paired metastatic and non-metastatic LNs obtained from patients with treatment-naïve breast cancer. Tumor metastasis decreases immunoregulatory LEC subsets, such as PD-L1 + subcapsular sinus LECs, while inducing an increase in capillary-like CD200 + HEY1 + LECs. Matrix Gla protein (MGP) was the most upregulated gene in metastatic LN LECs, and its expression on LECs was TGF-β and VEGF dependent. Upregulated MGP promotes cancer cell adhesion to LN lymphatics. Thus, breast cancer cell metastasis to LNs remodels LEC subsets in human LNs and escalates MGP expression, potentially facilitating cancer cell dissemination through the lymphatic system.
- Open Access
- 17 January 2022
- Published by Taylor & Francis in Annals of Medicine
- Vol. 54 (1) , 244-252
Increased incidence of melanoma in children and adolescents in Finland in 1990–2014: nationwide re-evaluation of histopathological characteristics
Changes in the incidence of melanoma in children and adolescents have been reported in Europe and in the USA in the recent decades.The aim of this study was to examine the incidence of paediatric a...
- 17 January 2022
- Published by Taylor & Francis in Annals of Medicine
- Vol. 54 (1) , 244-252
Open AccessIncreased incidence of melanoma in children and adolescents in Finland in 1990–2014: nationwide re-evaluation of histopathological characteristics
Changes in the incidence of melanoma in children and adolescents have been reported in Europe and in the USA in the recent decades.The aim of this study was to examine the incidence of paediatric a...
- Open Access
- 5 January 2022
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 10 (1S) , 2
OP3: Cutaneous Melanoma in Children, Adolescents and Young Adults
- 5 January 2022
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery - Global Open
- Vol. 10 (1S) , 2
Open AccessOP3: Cutaneous Melanoma in Children, Adolescents and Young Adults